Patients' Perspectives
Inflammatory Breast Cancer
 

This document is NOT intended to provide you with medical advice.  You should consult qualified practitioners in your area for such information. 

Inflammatory breast cancer (IBC) is one of the most advanced forms of breast cancer.  It can result from one of two things: The characteristic peau d'orange means that the skin over the breast literally has the texture of the skin of an orange because there are little bumps, usually red or purple, which indicate the presence of tumor cells in the dermal lymphatics (lymph glands in the skin). Among patients, this is familiarly known as "skin crud".

Another characteristic is that the surface of the skin will appear inflammed in general. The inflammation may be range from bright red to dark purpley red such that some women think they've accidentally bruised themselves, except for the fact that the initial appearance is purpley rather than the typical blue color of a bruise followed by a gradual change to purple and then yellow as a bruise would heal.

The third characteristic is that surface temperature of the skin literally is a couple of degrees higher than skin in the area around the inflammation or on the other breast. A handy way to confirm this is to put one hand on the breast that seems to be inflammed and the other on your abdomen or other breast. If you sense a difference in temperature, that's a signal to alert your physician to the possibility of IBC.

Until there's a biopsy or surgery to get a pathology report, patients who are thought to have IBC from external clinical examination are staged as Stage IIIb unless they have identifiable metastatic disease at the time of diagnosis in which case they're staged at Stage IV. In any case, the best diagnosis for IBC is that it is considered to be locally advanced disease due to the presence of peau d'orange on the skin surface.

The only way the IBC diagnosis can be absolutely confirmed is through biopsy and/or surgery so that there is a pathology report to provide the confirmation.

Many oncologists consider that a patient with IBC, regardless of any other characteristics of the tumor such as ploidy, estrogen-receptor, S-phase, or her-2 overexpression, has an aggressive form of breast cancer and treats the patient with the biggest hammer available. In the US today, many oncologists consider that the biggest hammer is considered to be high-dose chemotherapy with stem cell rescue, though other, presumably less aggressive, treatments are available and have been used successfully for some patients.

Where to find out more about:
Inflammatory breast cancer

More information can be found at the Inflammatory Breast Cancer web site which also has a listserve associated with it.

You can also learn more about inflammatory breast cancer from the National Cancer Institute's web site.



For more information, please send email to:
 
The Webmaster

or, answer our very short survey 


Legal stuff:

None of the essays entitled Patients' Perspectives is intended to provide medical, legal, or psycho-social advice. For those kinds of information, you should contact qualified practitioners in your local area. We do intend to convey our members' experiences with the various procedures involved in cancer treatment from the perspective of the patient to help educate patients and their caregivers. 

Copyright 2005 You Are Not Alone
Most recent update: 04 Oct 2005 22:06
To comment on the content of this page, send email to:
The Webmaster